Persei vivarium promotes UR-CARE and E-QUALITY at ECCO’26, the leading international IBD congress
ECCO’26, this year’s edition of the leading international congress on Inflammatory Bowel Disease (IBD), took place from February 18 to 21 in Stockholm. Once again, Persei vivarium participated through the projects UR-CARE and E-QUALITY.
How do Digital Therapeutics (DTx) help address the challenges facing healthcare systems?
Today, healthcare systems worldwide are facing major challenges driven by population ageing and the rising prevalence of chronic diseases. This situation is leading to growing demand for healthcare services and increasing healthcare expenditure. As a result, there is an urgent need to move towards more preventive, personalised, and value-based care models.
5 Key Trends Shaping the Digital Health Sector in 2026
Technological transformation continues to redefine healthcare. Today, technology and healthcare delivery no longer evolve separately, but advance together, reinforcing each other in a continuous cycle of innovation. Looking ahead to 2026, Digital Health is entering a phase of growth and maturity, consolidating the progress achieved in recent years.
Persei vivarium wishes you a very Merry Christmas and a fantastic 2026!
The Persei vivarium team would like to wish you a Merry Christmas and a New Year filled with health, joy, and new projects. May these days be a time to share, recharge, and look ahead to a year full of opportunities, excitement, and new challenges to embrace.
Digital Therapeutics (DTx): How Are These Solutions Evolving in Spain in 2025?
Digital Therapeutics (DTx) continue to experience exponential growth, emerging as innovative solutions that are transforming how we prevent, manage, and treat a wide range of diseases and conditions. Over the past three years, investment in DTx companies has reached an estimated EUR 1 billion, a 92% increase compared with the cumulative total of the previous six years.
Persei vivarium renews its B Corp certification, reaffirming its commitment to a positive impact on health and people
Persei vivarium, which first obtained B Corp Certification in 2022, has successfully completed its recertification process, a rigorous evaluation carried out every three years to ensure continuous improvement and alignment between purpose, practices, and social and environmental impact results.